These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39065650)

  • 1. Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA-PB1 Subunits Interaction.
    Giacchello I; Cianciusi A; Bertagnin C; Bonomini A; Francesconi V; Mori M; Carbone A; Musumeci F; Loregian A; Schenone S
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions.
    Massari S; Desantis J; Nizi MG; Cecchetti V; Tabarrini O
    ACS Infect Dis; 2021 Jun; 7(6):1332-1350. PubMed ID: 33044059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.
    Pismataro MC; Felicetti T; Bertagnin C; Nizi MG; Bonomini A; Barreca ML; Cecchetti V; Jochmans D; De Jonghe S; Neyts J; Loregian A; Tabarrini O; Massari S
    Eur J Med Chem; 2021 Oct; 221():113494. PubMed ID: 33962311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase.
    Massari S; Bertagnin C; Pismataro MC; Donnadio A; Nannetti G; Felicetti T; Di Bona S; Nizi MG; Tensi L; Manfroni G; Loza MI; Sabatini S; Cecchetti V; Brea J; Goracci L; Loregian A; Tabarrini O
    Eur J Med Chem; 2021 Jan; 209():112944. PubMed ID: 33328103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.
    D'Agostino I; Giacchello I; Nannetti G; Fallacara AL; Deodato D; Musumeci F; Grossi G; Palù G; Cau Y; Trist IM; Loregian A; Schenone S; Botta M
    Eur J Med Chem; 2018 Sep; 157():743-758. PubMed ID: 30142611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.
    Massari S; Goracci L; Desantis J; Tabarrini O
    J Med Chem; 2016 Sep; 59(17):7699-718. PubMed ID: 27046062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.
    Reuther P; Mänz B; Brunotte L; Schwemmle M; Wunderlich K
    J Virol; 2011 Dec; 85(24):13298-309. PubMed ID: 21957294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.
    Massari S; Nannetti G; Desantis J; Muratore G; Sabatini S; Manfroni G; Mercorelli B; Cecchetti V; Palù G; Cruciani G; Loregian A; Goracci L; Tabarrini O
    J Med Chem; 2015 May; 58(9):3830-42. PubMed ID: 25856229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity.
    Desantis J; Nannetti G; Massari S; Barreca ML; Manfroni G; Cecchetti V; Palù G; Goracci L; Loregian A; Tabarrini O
    Eur J Med Chem; 2017 Sep; 138():128-139. PubMed ID: 28666191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation.
    Liu H; Yao X
    Mol Pharm; 2010 Feb; 7(1):75-85. PubMed ID: 19883112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex.
    Deng T; Engelhardt OG; Thomas B; Akoulitchev AV; Brownlee GG; Fodor E
    J Virol; 2006 Dec; 80(24):11911-9. PubMed ID: 17005651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.
    Da Costa B; Sausset A; Munier S; Ghounaris A; Naffakh N; Le Goffic R; Delmas B
    J Virol; 2015 Jun; 89(12):6376-90. PubMed ID: 25855727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance.
    Nannetti G; Massari S; Mercorelli B; Bertagnin C; Desantis J; Palù G; Tabarrini O; Loregian A
    Antiviral Res; 2019 May; 165():55-64. PubMed ID: 30885750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.
    Li C; Wang Z; Cao Y; Wang L; Ji J; Chen Z; Deng T; Jiang T; Cheng G; Qin FX
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. China makes an impressive breakthrough in avian influenza virus research - Discovering the "heart" of avian infl uenza virus.
    Li YG; Wu JF; Li X
    Drug Discov Ther; 2009 Feb; 3(1):1. PubMed ID: 22495459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction.
    Tintori C; Laurenzana I; Fallacara AL; Kessler U; Pilger B; Stergiou L; Botta M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):280-2. PubMed ID: 24314669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase.
    Wunderlich K; Juozapaitis M; Ranadheera C; Kessler U; Martin A; Eisel J; Beutling U; Frank R; Schwemmle M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):696-702. PubMed ID: 21135188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.
    He X; Zhou J; Bartlam M; Zhang R; Ma J; Lou Z; Li X; Li J; Joachimiak A; Zeng Z; Ge R; Rao Z; Liu Y
    Nature; 2008 Aug; 454(7208):1123-6. PubMed ID: 18615018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead Optimization of Influenza Virus RNA Polymerase Inhibitors Targeting PA-PB1 Interaction.
    Mizuta S; Otaki H; Ishikawa T; Makau JN; Yamaguchi T; Fujimoto T; Takakura N; Sakauchi N; Kitamura S; Nono H; Nishi R; Tanaka Y; Takeda K; Nishida N; Watanabe K
    J Med Chem; 2022 Jan; 65(1):369-385. PubMed ID: 34905383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
    Li C; Ba Q; Wu A; Zhang H; Deng T; Jiang T
    FEBS J; 2013 Feb; 280(4):1139-49. PubMed ID: 23279951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.